NeuroNascent Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Series A
  • (Cancelled)

  • Latest Deal Amount
  • $20M

  • Investors
  • 5

NeuroNascent General Information

Description

Developer of a neuron regeneration therapeutics intended to offer treatment for reversing neurological disorders. The company's developed molecule helps to treat brain disorders that include Alzheimer's disease, Parkinson's disease, fragile X syndrome, and Down syndrome, enabling healthcare professionals to have drugs for the medication of neurodegenerative diseases.

Contact Information

Website
www.neuronascent.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6030 Day Break Circle
  • A150 - PMB244
  • Clarksville, MD 21029
  • United States
+1 (410)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
LOHAS & Wellness, Life Sciences
Corporate Office
  • 6030 Day Break Circle
  • A150 - PMB244
  • Clarksville, MD 21029
  • United States
+1 (410)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroNascent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series A) 10-Mar-2021 $20M Cancelled Pre-Clinical Trials
6. Grant 19-Sep-2018 Completed Pre-Clinical Trials
5. Later Stage VC 17-Mar-2015 Completed Pre-Clinical Trials
4. Grant 23-May-2011 Completed Pre-Clinical Trials
3. Early Stage VC 13-Oct-2008 Completed Pre-Clinical Trials
2. Grant 23-Jan-2008 $50K $100K Completed Pre-Clinical Trials
1. Early Stage VC 06-Nov-2007 $100K $100K Completed Pre-Clinical Trials
To view NeuroNascent’s complete valuation and funding history, request access »

NeuroNascent Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a neuron regeneration therapeutics intended to offer treatment for reversing neurological disorders. The co
Drug Discovery
Clarksville, MD
3 As of 2024

Boston, MA
 

Seattle, WA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NeuroNascent Competitors (57)

One of NeuroNascent’s 57 competitors is CervoMed, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CervoMed Formerly VC-backed Boston, MA
Mozart Therapeutics Venture Capital-Backed Seattle, WA
CuraSen Venture Capital-Backed San Carlos, CA
T3D Therapeutics Venture Capital-Backed Durham, NC
Neurona Therapeutics Venture Capital-Backed South San Francisco, CA
You’re viewing 5 of 57 competitors. Get the full list »

NeuroNascent Patents

  • 50

    Total Documents Applications and Grants

  • Total Patents Families

  • 36

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

NeuroNascent Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3220429-A1 Methods and compositions for lipid formulation of lipophilic small molecule therapies of the heterocyclic type Pending 11-Jun-2021
AU-2022289728-A1 Methods and compositions for lipid formulation of lipophilic small molecule therapies of the heterocyclic type Pending 11-Jun-2021
EP-4352058-A1 Methods and compositions for lipid formulation of lipophilic small molecule therapies of the heterocyclic type Pending 11-Jun-2021
US-20240285646-A1 Methods and compositions for lipid formulation of lipophilic small molecule therapies of the heterocyclic type Pending 11-Jun-2021
EP-2480233-A1 Methods and pharmaceutical compositions for treating down syndrome Inactive 22-Sep-2009 A61K31/47
To view NeuroNascent’s complete patent history, request access »

NeuroNascent Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuroNascent Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Institute On Aging Government
Maryland Biotechnology Center Government
Maryland Industrial Partnerships University Minority
Maryland Department of Commerce Government Minority
TEDCO Venture Capital Minority
To view NeuroNascent’s complete investors history, request access »

Ready to get started?

Request a free trial

NeuroNascent FAQs

  • When was NeuroNascent founded?

    NeuroNascent was founded in 2004.

  • Where is NeuroNascent headquartered?

    NeuroNascent is headquartered in Clarksville, MD.

  • What is the size of NeuroNascent?

    NeuroNascent has 3 total employees.

  • What industry is NeuroNascent in?

    NeuroNascent’s primary industry is Drug Discovery.

  • Is NeuroNascent a private or public company?

    NeuroNascent is a Private company.

  • What is NeuroNascent’s current revenue?

    The current revenue for NeuroNascent is .

  • How much funding has NeuroNascent raised over time?

    NeuroNascent has raised $1.42M.

  • Who are NeuroNascent’s investors?

    National Institute On Aging, Maryland Biotechnology Center, Maryland Industrial Partnerships, Maryland Department of Commerce, and TEDCO have invested in NeuroNascent.

  • Who are NeuroNascent’s competitors?

    CervoMed, Mozart Therapeutics, CuraSen, T3D Therapeutics, and Neurona Therapeutics are some of the 57 competitors of NeuroNascent.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »